Fibromyalgia affects millions globally with chronic pain that often resists conventional treatment, driving patients toward non-drug alternatives with mixed scientific support. This comprehensive evaluation of electrical nerve stimulation research reveals both promise and significant limitations for pain management.
This umbrella review analyzed nine systematic reviews examining transcutaneous electrical nerve stimulation (TENS) effectiveness in fibromyalgia patients. The analysis found modest short-term pain reduction when higher-intensity electrical stimulation was applied for at least 10 treatment sessions. However, improvements in functional capacity, sleep quality, and psychosocial wellbeing remained inconsistent across studies, with most failing to reach clinically meaningful thresholds for patient benefit.
The findings align with decades of mixed TENS research across chronic pain conditions, where temporary neural interference can provide relief but rarely addresses underlying pain mechanisms. For fibromyalgia specifically, this suggests TENS may serve as an adjunct therapy rather than a primary intervention. The emphasis on higher intensities and extended treatment courses indicates that brief, low-intensity applications common in clinical practice may be inadequate. Most concerning is the lack of robust functional improvement data, since fibromyalgia patients prioritize restored daily activities over pain scores alone. The heterogeneity in study protocols also complicates clinical decision-making, as optimal stimulation parameters remain unclear. While TENS offers a low-risk option for motivated patients, these results suggest tempering expectations and focusing resources on interventions with stronger evidence for comprehensive symptom management in fibromyalgia.